DR info

Clinical trials : 41 / Drugs : 46 - (DrugBank : 9) / Drug target genes : 11 - Drug target pathways : 15

Charcot-Marie-Tooth disease and other diseases between which drug repositioning (DR) might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Score (Drug repositionability)

ID	Diseases (Sorted by score)	Score
10	Charcot-Marie-Tooth disease	-
13	Multiple sclerosis/Neuromyelitis optica	11.000
46	Malignant rheumatoid arthritis	7.443
231	Alpha-1-antitrypsin deficiency	6.317
298	Hereditary pancreatitis	6.148
226	Interstitial cystitis with Hunners ulcer	6.091
70	Spinal stenosis	6.083
51	Scleroderma	5.973
97	Ulcerative colitis	5.940
96	Crohn disease	5.922
6	Parkinson disease	5.911
2	Amyotrophic lateral sclerosis	4.558
168	Ehlers-Danlos syndrome	3.788
1	Spinal and bulbar muscular atrophy	3.636
36	Epidermolysis bullosa	3.607
86	Pulmonary arterial hypertension	3.436
38	Stevens-Johnson syndrome	3.182
114	Non-dystrophic myotonia syndrome	3.030
256	Muscle glycogenosis	2.713
127	Frontotemporal lobar degeneration	2.614
58	Hypertrophic cardiomyopathy	2.557
140	Dorabe syndrome	2.557
144	Lennox-Gastaut syndrome	2.551
193	Prader-Willi syndrome	2.540
107	Juvenile idiopathic arthritis	2.535
53	Sjogren syndrome	2.521
113	Muscular dystrophy	2.504
28	Systemic amyloidosis	2.479
156	Rett syndrome	2.450
84	Sarcoidosis	2.439
8	Huntington disease	2.435
34	Neurofibromatosis	2.429
149	Hemiconvulsion hemiplegia epilepsy syndrome	2.053
43	Microscopic polyangiitis	1.286
45	Eosinophilic granulomatosis with Polyangiitis	1.182
44	Wegener granulomatosis	1.130
40	Takayasu arteritis	1.080
42	Polyarteritis nodosa	1.070
41	Giant cell arteritis	1.017